References

Abtahi, H., A.H. Salmanian, S. Rafati, G. Behzadian Nejad and Z.M. Hassan, 2004. High level expression of recombinant ribosomal protein (L7/L12) from Brucella abortus and its reactivity with infected human sera. Iran. Biomed. J., 8: 13-18.
Direct Link  |  

Al-Mariri, A., A. Tibor, P. Mertens, X. De Bolle and P. Michel et al., 2001. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella sp. Infect. Immunol., 69: 6264-6270.
PubMed  |  

Alton, G.G., L.M. Jones, R.D. Angus and J.M. Verger, 1988. Techniques for the Brucellosis Laboratory. 1st Edn., Institute Nationale de le Rech, France, Paris, Pages: 174.

Cassataro, J., C.A. Velikovsky and L. Bruno, 2007. Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting. Clin. Vaccine Immunol., 14: 869-874.
PubMed  |  

Cassataro, J., S.M. Estein, K.A. Pasquevich, C.A. Velikovsky and S. de la Barrera et al., 2005. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4 T-helper-1 response that protects against Brucella melitensis infection. Infect. Immunol., 73: 8079-8088.
PubMed  |  

Cassatro, J., A.V. Carlos, D. Silvia, S. Estein and L. Bruno et al., 2005. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Infect. Immunol., 73: 6537-6546.
PubMed  |  Direct Link  |  

Cloeckaert, A., J.M. Verger, M. Grayon, M.S. Zygmunt and O. Grepinet, 1996. Nucleotide sequence and expression of the gene encoding the major 25-Kilodalton outer membrane protein of Brucella ovis: Evidence for antigenic shift, compared with other Brucella sp., due to a deletion in the gene. Infect. Immunol., 64: 2047-2055.
PubMed  |  

Cloeckaert, A., N. Vizcaino, J.Y. Paquet, R.A. Bowden and P.H. Elzer, 2002. Major outer membrane proteins of Brucella sp.: Past, present and future. Vet. Microbiol., 90: 229-247.
CrossRef  |  PubMed  |  Direct Link  |  

Delpino, M.V., S.M. Estein, C.A. Fossati and P.C. Baldi, 2007. Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria. Clin. Vaccine Immunol., 14: 1296-1301.
PubMed  |  

Dubray, G. and G. Bezard, 1980. Isolation of three protective cell-wall antigens of Brucella abortus in experimental brucellosis in mice. Ann. Rech. Vet., 11: 367-372.
PubMed  |  

Gurunathan, S., C.Y. Wu, B.L. Freidag and R.A. Seder, 2000. DNA vaccines: A key for inducing long-term cellular immunity. Curr. Opin. Immunol., 12: 442-447.
CrossRef  |  PubMed  |  Direct Link  |  

Leclero, S., J.S. Harms, G.M. Rosinha, V. Azevedo and S.C. Oliveira, 2002. Induction of a Th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus GroEL heat-shock gene. J. Med. Microbiol., 51: 20-26.
PubMed  |  

Letesson, J.J., A. Tibor, G.V. Eynde, V. Wansard, V. Weynants, P. Denoel and E. Saman, 1997. Humoral immune responses of Brucella-infected cattle, sheep and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol., 4: 556-564.
PubMed  |  

Morgan, W.J. and M.J. Corbel, 1976. Recommendations for the description of species and biotypes of the genus Brucella. Dev. Biol. Stand., 31: 27-37.
PubMed  |  

Murphy, E.A., J. Sathiyaseelan, M.A. Parent, B. Zou and C.L. Baldwin, 2001. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology, 103: 511-518.
PubMed  |  

Onate, A.A., R. Vemulapalli, E. Andrews, G.G. Schuring, S. Boyle and H. Folch, 1999. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect. Immunol., 67: 986-988.
PubMed  |  

Sauret, J.M. and M.D. Natalia-Vilissova, 2001. Human brucellosis. J. Am. Board Family Pract., 15: 401-405.
PubMed  |  

Schurig, G.G., N. Sriranganathan and M.J. Corbel, 2002. Brucellosis vaccines: Past, present and future. Vet. Microbiol., 90: 479-496.
CrossRef  |  Direct Link  |  

Vemulapalli, R., Y. He, S. Cravero, N. Sriranganathan, S.M. Boyle and G.G. Schurig, 2000. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect. Immunol., 68: 3286-3289.
PubMed  |  

Vizcaino, N., A. Cloeckaert, M. Aygniunt and G. Dubray, 1996. Cloning, nucleotide sequence and expression of the Brucella melitensis Omp31 gene coding for an immunogenic major outer membrane protein. Infect. Immunol., 64: 3744-3751.
PubMed  |  Direct Link  |  

Yang, X., M. Hudson, N. Walters, R.F. Bargatze and D.W. Pascual, 2005. Selection of protective epitopes for Brucella melitensis by DNA vaccination. Inform. Immunol., 73: 7297-7303.
PubMed  |